Atlas Trials

Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

Clinical trial NCT05963568 · RECRUITING

Trial details

NCT number
NCT05963568
Sponsor
Northern California Institute of Research and Education
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
StrokeMedication Adherence
Start date
2026-04-01
Primary completion
2029-01-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.